Caplin Point clears INVIMA inspection for Puducherry injectables plant

Caplin Point Laboratories Limited successfully completed an inspection by INVIMA – Colombia at its injectables facility located in Puducherry. The inspection, which took place between December 8 and 12, 2025, concluded without any issues.

Chairman C.C. Paarthipan highlighted that this achievement reinforces the company's commitment to expanding its reach in Latin America, providing high-quality, affordable medicines to the region's patient population. He further noted this as a crucial milestone in their product strategy for expanding into the broader Latin American market for specialty injectable products, complementing their existing INVIMA-approved Softgel section at the same site.